AZN vs NVS: stock comparison and AI forecast
Astrazeneca Plc (AZN) and Novartis Ag (NVS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AZN Astrazeneca Plc
- Price
- $186.58 +1.7% · 6M
- Market Cap
- $285.01B
- P/E Ratio
- 13.3x
- Size
- mega-cap
- AI Forecast
NVS Novartis Ag
- Market Cap
- $308.20B
- P/E Ratio
- 9.7x
- Size
- mega-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- AZN and NVS have similar market capitalizations ($285.01B and $308.20B).
- NVS trades at 9.7 times trailing earnings, AZN at 13.3 times.
- NVS carries 1.40 times debt per unit of equity, against 1.34 times for AZN.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AZN | NVS |
|---|---|---|
| Market Cap | $285.01B | $308.20B |
| P/E Ratio | 13.28x | 9.69x |
| EPS | $13.85 | $16.67 |
| Revenue/Share | $90.46 | – |
| FCF/Share | $20.96 | $23.48 |
Profitability & Margins
| Metric | AZN | NVS |
|---|---|---|
| ROE | 44.5% | 72.0% |
| ROA | 19.0% | 29.9% |
| ROIC | 36.0% | 49.1% |
| Gross Margin | 81.8% | – |
| Operating Margin | 21.4% | – |
| Net Margin | 15.4% | – |
| EBT Margin | 19.0% | – |
| Tax Rate | 18.7% | 13.5% |
Financial Health
| Metric | AZN | NVS |
|---|---|---|
| Current Ratio | 0.94x | 1.12x |
| Quick Ratio | 0.72x | 0.89x |
| D/E Ratio | 1.34x | 1.40x |
| Financial Leverage | 2.34x | 2.41x |
| Working Capital | -$1.89B | $3.18B |
Cash Flow
| Metric | AZN | NVS |
|---|---|---|
| Operating Cash Flow | $39.11B | $48.30B |
| Free Cash Flow | $32.48B | $44.80B |
| Capital Spending | -$6.62B | -$3.50B |
| OCF Growth YoY | 32.6% | 34.1% |
| FCF Growth YoY | 0.0% | 0.0% |
| FCF/Sales | 23.2% | – |
| CapEx/Sales | 4.7% | – |
Operational Efficiency
| Metric | AZN | NVS |
|---|---|---|
| Asset Turnover | 1.23x | – |
| Receivables Turnover | 9.2x | – |
| Inventory Turnover | 3.9x | 5.3x |
| Fixed Assets Turnover | 10.8x | – |
| Days Sales Outstanding | 40 days | – |
| Days Inventory | 94 days | 69 days |
| Payables Period | 362 days | – |
| Cash Conversion Cycle | -229 days | – |
Income Statement
| Metric | AZN | NVS |
|---|---|---|
| Total Revenue | $140.21B | – |
| Operating Income | $30.00B | $41.07B |
| Net Income | $21.64B | $33.21B |
| R&D Expense | $34.37B | $26.32B |
| SG&A Expense | $49.70B | $32.35B |
| Cost of Goods Sold | $25.50B | $33.02B |
Dividend & Shareholder Information
| Metric | AZN | NVS |
|---|---|---|
| Shares Outstanding | 1550M | 1908M |
| Net Income Growth | 89.5% | 28.6% |
| EPS Growth | 89.2% | 37.2% |
AZN vs NVS: stock comparison and AI forecast
Which is bigger, AZN or NVS?
AZN and NVS have similar market capitalizations ($285.01B and $308.20B).
Which is cheaper on earnings, AZN or NVS?
NVS trades at 9.7 times trailing earnings, AZN at 13.3 times.
Which one does Intratio's AI model rank higher, AZN or NVS?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.